RNAC – cartesian therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
What Makes Cartesian Therapeutics, Inc. (RNAC) a New Buy Stock [Yahoo! Finance]
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $54.00 price target on the stock.
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $42.00 price target on the stock.
Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Form SC 13G/A Cartesian Therapeutics, Filed by: FMR LLC
Form 10-Q Cartesian Therapeutics, For: Mar 31
Form 8-K Cartesian Therapeutics, For: May 08
Form DEF 14A Cartesian Therapeutics, For: Dec 31
Form DEFA14A Cartesian Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.